Kala Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, today announced that members of its management team will participate in the following upcoming conferences: H.C. Wainwright 20th Annual Global Investment ConferenceDate: Wednesday, September 5Presentation Time: 3:00 p.m. ETLocation: New York, NY 2018 Wells Fargo H

Full Story →